Inogen, Inc. Q4 2025 Earnings Call Summary

Inogen, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Transformation and Performance Drivers Achieved a strategic pivot from a single-product oxygen company to a diversified respiratory platform spanning oxygen, sleep therapy, airway clearance, and digital health. Delivered first full year of positive adjusted EBITDA since 2021, driven by disciplined cost management and operational leverage from a 4% revenue increase. Attributed 20% unit volume growth to the ongoing market conversion from trad ...